Index of artpub/2024/311095/

Puig, Noemí
Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial
2024
https://ddd.uab.cat/record/311095